-
Get the latest information and research on osteoporosis.
-
Find treatment, guidance and advice on living with osteoporosis.
-
Share your experience and get involved. Joining the conversation is the first step to ending osteoporosis and broken bones.
Institute of Medicine (IOM) updates vitamin D recommendations
Today the Institute of Medicine (IOM) released updated recommendations regarding calcium and vitamin D intake. IOM recommends 600 international units (IU) of vitamin D every day for most healthy adults under age 71 and 800 IU for healthy people age 71 and older. The updated IOM recommendations for vitamin D intake are sufficient for most healthy adults, however, some adults may need more. These include those with very little sun exposure (or who consistently wear sun screen or protective clothing), dark skin, osteoporosis, problems absorbing dietary fat or who are taking medicines that interfere with vitamin D.
This is an increase from the previous IOM recommendations that cited 200 to 400 IU per day for healthy adults under age 71 and 600 IU per day for those age 71 and older. Since 2008, NOF has recommended that healthy people age 19 to 49 get 400 to 800 IU of vitamin D every day; and that adults age 50 and older get 800 to 1,000 IU every day.
NOF’s recommendations for daily intake remain higher than IOM’s but fall well within the margin of safety.
The IOM report issued on November 30, 2010 set the safe upper limit for daily intake to be 4,000 IU. The IOM report did not address the vitamin D requirements for high risk individuals or those who require treatment. NOF strongly recommends that you consult with your healthcare professional for your particular requirements.
NOF applauds IOM for their comprehensive review of the evidence supporting their updated recommendations for vitamin D and calcium intake.
Click here to read NOF’s Bone Basics on Vitamin D to learn more.
The latest
Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.
In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."
CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.
Explore by tag
